Olanzapine (Zyprexa, Zyprexa Zydis)
https://libcat.nshealth.ca/en/permalink/chpams35690
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1669
- Available Online
- View Pamphlet
Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (LCSH)
- Antipsychotic drugs
- Manic-depressive illness
- Schizophrenia--Treatment
- Specialty
- Medications
- Abstract
- Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Responsibility
- Prepared by: Pharmacy Services
- Pamphlet Number
- 1669
Paliperidone (Invega®) and paliperidone palmitate (Invega Sustenna®, Invega Trinza®
https://libcat.nshealth.ca/en/permalink/chpams36494
Nova Scotia Health Authority. QE II. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1938
- Available Online
- View Pamphlet
Paliperidone is most often used to treat psychosis or mania. This pamphlet explains how to take paliperidone, what symptoms it will help with, and possible side effects. Rare, serious side effects that require a visit to the Emergency Department are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QE II. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Paliperidone Palmitate - therapeutic use
- Psychotic Disorders - drug therapy
- Mania - drug therapy
- Subjects (LCSH)
- Psychoses--Treatment
- Mania
- Specialty
- Medications
- Abstract
- Paliperidone is most often used to treat psychosis or mania. This pamphlet explains how to take paliperidone, what symptoms it will help with, and possible side effects. Rare, serious side effects that require a visit to the Emergency Department are listed.
- Notes
- Previous title: Paliperidone (Invega); Paliperidone Palmitate (Invega Sustenna)
- Responsibility
- Prepared by: Pharmacy Services, QE II
- Pamphlet Number
- 1938
Nova Scotia Health Authority. CVAD Practice Committee.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 1571
- Available Online
- View Pamphlet
A PICC (peripherally inserted central catheter) line is a long intravenous (I.V.) catheter (tube). It is put into a vein in your arm and threaded into a vein above your heart. This pamphlet explains how it will be inserted, risks, taking care of your line, and symptoms to watch for.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. CVAD Practice Committee
- Alternate Title
- Peripherally inserted central catheter line
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (10 p.) : digital, PDF file
- Subjects (MeSH)
- Catheterization, Peripheral
- Medications
- Subjects (LCSH)
- Catheterization
- Drugs
- Specialty
- Medications
- Abstract
- A PICC (peripherally inserted central catheter) line is a long intravenous (I.V.) catheter (tube). It is put into a vein in your arm and threaded into a vein above your heart. This pamphlet explains how it will be inserted, risks, taking care of your line, and symptoms to watch for.
- Responsibility
- Prepared by: CVAD Practice Committee
- Pamphlet Number
- 1571
Polyoma virus and BK virus
https://libcat.nshealth.ca/en/permalink/chpams35425
Nova Scotia Health Authority. Kidney Transplant Clinic.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1510
- Available Online
- View Pamphlet
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Kidney Transplant Clinic
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Polyomavirus
- BK Virus
- Kidney Transplantation - adverse effects
- Immunosuppressive Agents - adverse effects
- Subjects (LCSH)
- Polyomaviruses
- Kidneys--Transplantation
- Immunosuppressive agents
- Specialty
- Nephrology
- Medications
- Abstract
- BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of BK virus, how BK virus is diagnosed, and how it is treated.
- Responsibility
- Prepared by: Kidney Transplant Clinic
- Pamphlet Number
- 1510
Risankizumab (Skyrizi®) therapy for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams38191
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 2345
- Available Online
- View Pamphlet
Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Alternate Title
- Risankizumab (Skyrizi®) therapy for IBD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (9 p.) : digital, PDF file
- Subjects (MeSH)
- Inflammatory Bowel Diseases - drug therapy
- Subjects (LCSH)
- Inflammatory bowel diseases
- Specialty
- Gastrointestinal System
- Medications
- Abstract
- Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
- Responsibility
- Prepared by: Nova Scotia Collaborative IBD Program
- Pamphlet Number
- 2345
Risperidone (Risperdal, Risperdal Consta)
https://libcat.nshealth.ca/en/permalink/chpams35648
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1639
- Available Online
- View Pamphlet
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Risperidone
- Subjects (LCSH)
- Antipsychotic drugs
- Specialty
- Medications
- Abstract
- Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Responsibility
- Prepared by: Pharmacy Services
- Pamphlet Number
- 1639
Services de pharmacie d’hôpital
https://libcat.nshealth.ca/en/permalink/chpams36739
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 2108
- Available Online
- View Pamphlet
Les Services de pharmacie d’hôpital comptent des pharmaciens et des assistants en pharmacie, qui sont des membres importants de votre équipe de soins de santé. Grâce à leurs connaissances sur les médicaments, ils offrent des soins dans tous les secteurs de la Régie de la santé de la Nouvelle-Écosse (la Régie). La brochure décrit les services offerts, dont la préparation des médicaments, les antécédents pharmaceutiques, la gestion de la pharmacothérapie, les renseignements sur les médicaments, l…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Alternate Title
- Hospital pharmacy services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- French
- Physical Description
- 1 electronic document (4 p.) : digital, PDF file
- Subjects (MeSH)
- Pharmacy Service, Hospital
- Pharmaceutical Services
- Subjects (LCSH)
- Hospital pharmacies
- Pharmaceutical services
- Specialty
- Medications
- Abstract
- Les Services de pharmacie d’hôpital comptent des pharmaciens et des assistants en pharmacie, qui sont des membres importants de votre équipe de soins de santé. Grâce à leurs connaissances sur les médicaments, ils offrent des soins dans tous les secteurs de la Régie de la santé de la Nouvelle-Écosse (la Régie). La brochure décrit les services offerts, dont la préparation des médicaments, les antécédents pharmaceutiques, la gestion de la pharmacothérapie, les renseignements sur les médicaments, la promotion de la santé, l’apprentissage, l’enseignement et la recherche, l’information et l’examen des médicaments.
- This pamphlet is a French translation of "Hospital Pharmacy Services" pamphlet 1501. The hospital Pharmacy Department includes pharmacists and pharmacy practice assistants, who are important members of your health care team. They offer medication knowledge and care in all areas of Nova Scotia Health Authority (NSHA). This pamphlet describes services offered such as: medical preparation, medication history, medication management, medication teaching, health promotion, learning, teaching, and research, and medication information and review.
- Responsibility
- Prepared by: Pharmacy Services
- Pamphlet Number
- 2108
Nova Scotia Health Authority. QEII. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 0075
- Available Online
- View Pamphlet
Statins are medications used to help lower high cholesterol levels. This pamphlet explains how to take and store this medication. Possible side effects are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Subjects (LCSH)
- Statins (Cardiovascular agents)
- Specialty
- Medications
- Abstract
- Statins are medications used to help lower high cholesterol levels. This pamphlet explains how to take and store this medication. Possible side effects are listed.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0075
Taking your medication
https://libcat.nshealth.ca/en/permalink/chpams34640
Nova Scotia Health Authority. Mental Health and Addictions Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 0758
- Available Online
- View Pamphlet
Taking your medication is an important part of your treatment. It means you are playing an active role in keeping up your health and well-being. This pamphlet explains why some people stop taking their medication. If these or other issues concern you, please talk to your primary health care provider. They can help you find solutions. Tips to help you take your medication are listed. The French version of this pamphlet 1916, "Prendre vos médicaments", is also available.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Mental Health and Addictions Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([1] p.) : digital, PDF file
- Subjects (MeSH)
- Psychiatry
- Medication
- Subjects (LCSH)
- Drugs
- Mental Health
- Specialty
- Medications
- Abstract
- Taking your medication is an important part of your treatment. It means you are playing an active role in keeping up your health and well-being. This pamphlet explains why some people stop taking their medication. If these or other issues concern you, please talk to your primary health care provider. They can help you find solutions. Tips to help you take your medication are listed. The French version of this pamphlet 1916, "Prendre vos médicaments", is also available.
- Responsibility
- Prepared by: Mental Health and Addictions Program
- Pamphlet Number
- 0758
Taking your medications when you are sick after a kidney transplant
https://libcat.nshealth.ca/en/permalink/chpams35858
Nova Scotia Health Authority. QEII. Kidney Transplant Clinic.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1805
- Available Online
- View Pamphlet
This pamphlet lists medications you should not take if you get very sick with diarrhea (loose, watery poop), or you are vomiting (throwing up). These medications keep your blood pressure down, and protect your kidneys and heart. They can also harm you if you do not have enough fluids in your body. Diarrhea and vomiting can make you dehydrated (not have enough fluids in your body). Information about what to do if you have not taken your medication(s) for more than 1 day (24 hours) and/or cannot …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Kidney Transplant Clinic
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Kidney transplantation
- Medications
- Subjects (LCSH)
- Kidneys--Transplantation
- Drugs
- Specialty
- Nephrology
- Medications
- Abstract
- This pamphlet lists medications you should not take if you get very sick with diarrhea (loose, watery poop), or you are vomiting (throwing up). These medications keep your blood pressure down, and protect your kidneys and heart. They can also harm you if you do not have enough fluids in your body. Diarrhea and vomiting can make you dehydrated (not have enough fluids in your body). Information about what to do if you have not taken your medication(s) for more than 1 day (24 hours) and/or cannot keep fluids down without vomiting is included.
- Notes
- Previous title: Taking your medications when you are ill after a kidney transplant : a guide for patients with a kidney transplant
- Responsibility
- Prepared by: Kidney Transplant Clinic, QEII
- Pamphlet Number
- 1805
Timbre de nitroglycérine
https://libcat.nshealth.ca/en/permalink/chpams36474
Nova Scotia Health Authority. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1911
- Available Online
- View Pamphlet
Ce document explique à quoi sert ce médicament et comment le prendre. Vous y découvrirez également ce qu’il faut faire si vous oubliez une dose, des conseils de conservation, des conseils sur les médicaments et les aliments à éviter et des avertissements. Il indique aussi les effets secondaires graves qui nécessitent une visite chez le médecin. ; This pamphlet is a French translation of "Nitroglycerin Patch" pamphlet 0251. This pamphlet explains what this medication is used for and how to take …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Department
- Alternate Title
- Timbre de nitro
- Nitroglycerin patch
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- French
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Nitroglycerin
- Subjects (LCSH)
- Nitroglycerin
- Specialty
- Medications
- Abstract
- Ce document explique à quoi sert ce médicament et comment le prendre. Vous y découvrirez également ce qu’il faut faire si vous oubliez une dose, des conseils de conservation, des conseils sur les médicaments et les aliments à éviter et des avertissements. Il indique aussi les effets secondaires graves qui nécessitent une visite chez le médecin.
- This pamphlet is a French translation of "Nitroglycerin Patch" pamphlet 0251. This pamphlet explains what this medication is used for and how to take it.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 1911
Treatment of high potassium with Kayexalate powder in hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 1445
- Available Online
- View Pamphlet
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (4 p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Polystyrene sulfonic acid
- Hyperkalemia
- Subjects (LCSH)
- Drugs
- Low-potassium diet
- Specialty
- Nephrology
- Medications
- Abstract
- Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
- Notes
- Previous title: Treatment of high potassium with Kayexalate powder in hemodialysis patients
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1445
Using medications safely when you have kidney disease
https://libcat.nshealth.ca/en/permalink/chpams38205
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 2357
- Available Online
- View Pamphlet
People with kidney disease often take many medications. These medications can help with your kidney disease and other medical conditions (like high blood pressure [hypertension] or diabetes). It is important to take your medications regularly and as told by your health care provider. This pamphlet explains what you need to know about your medications and non-prescription medications, how you can make sure your medications are OK for your level of kidney function, and what will happen if a medic…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Medications
- Kidney Diseases - drug therapy
- Subjects (LCSH)
- Drugs
- Kidney disease
- Specialty
- Medications
- Nephrology
- Abstract
- People with kidney disease often take many medications. These medications can help with your kidney disease and other medical conditions (like high blood pressure [hypertension] or diabetes). It is important to take your medications regularly and as told by your health care provider. This pamphlet explains what you need to know about your medications and non-prescription medications, how you can make sure your medications are OK for your level of kidney function, and what will happen if a medication is not safe for your level of kidney function. Information about what to do if you have questions is included.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2357
Ustekinumab (Stelara) therapy
https://libcat.nshealth.ca/en/permalink/chpams35722
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1695
- Available Online
- View Pamphlet
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taki…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (10 p.) : digital, PDF file
- Subjects (MeSH)
- Ustekinumab
- Inflammatory Bowel Diseases - drug therapy
- Subjects (LCSH)
- Inflammatory bowel diseases
- Crohn's disease
- Ulcerative colitis
- Specialty
- Medications
- Abstract
- Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taking ustekinumab and while you are taking it are listed. Possible side effects, information about pregnancy and breast/chest feeding, and other important things to know are included.
- Notes
- Previous title: Ustekinumab (Stelara) therapy for Crohn's disease
- Responsibility
- Prepared by: Nova Scotia Collaborative IBD Program
- Pamphlet Number
- 1695
Vedolizumab (Entyvio) therapy
https://libcat.nshealth.ca/en/permalink/chpams35620
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1623
- Available Online
- View Pamphlet
Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when und…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (11 p.) : digital, PDF file
- Subjects (MeSH)
- Gastrointestinal Agents
- Colitis, Ulcerative - drug therapy
- Crohn Disease - drug therapy
- Subjects (LCSH)
- Gastrointestinal agents
- Ulcerative colitis
- Crohn's disease
- Specialty
- Medications
- Abstract
- Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when undergoing this treatment are provided.
- Responsibility
- Prepared by: Nova Scotia Collaborative IBD Program
- Pamphlet Number
- 1623
Velphoro® (sucroferric oxyhydroxide) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams37620
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2307
- Available Online
- View Pamphlet
Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases - drug therapy
- Subjects (LCSH)
- Kidneys--Diseases--Treatment
- Specialty
- Nephrology
- Medications
- Abstract
- Velphoro® is a medication used to treat high levels of phosphorous in the blood. Phosphorous is a mineral that builds strong bones and teeth. Velphoro® binds (attaches) to phosphorous from the foods you eat and stops your body from taking it in. This pamphlet explains why someone with with chronic kidney disease (CKD) needs to take this medication, how to take and store it, and possible side effects.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2307
Warfarin sodium
https://libcat.nshealth.ca/en/permalink/chpams36501
Nova Scotia Health Authority. QEII. Pharmacy Services, Nova Scotia Health Authority. QEII. Hematology Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 0373
- Available Online
- View Pamphlet
Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the An…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Services
- Nova Scotia Health Authority. QEII. Hematology Services
- Alternate Title
- Coumadin
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Warfarin
- Anticoagulants
- Subjects (LCSH)
- Warfarin
- Anticoagulants (Medicine)
- Specialty
- Medications
- Abstract
- Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the Anticoagulation Clinic and the Thrombosis Anticoagulation Program is provided. The French translation of this pamphlet 2063, "Warfarine sodique" is also available.
- Notes
- Previous title: Warfarin sodium, an oral anticoagulant
- Responsibility
- Prepared by: Pharmacy Services and Hematology Services, QEII
- Pamphlet Number
- 0373
